Thanks for the heads up. Looks like some of the selling could of been due to the financials with some seeing it as a tax loss selling and looking at early next year as a chance to get in again. I do like seeing their cash position increasing. Also liabilities are not increasing so that is another positive. Did you notice in the notes that sales breakdown. Very nice to be able to kind of estimate Teva's order.